Balázs M, Tüske M
Acta Med Hung. 1986;43(4):407-11.
A total of 79 metastatic breast cancer patients were treated with a combination of vincristine, doxorubicin and cyclophosphamide (VDC). In 59% of the patients remission occurred, in 23% the condition did not change, while in 18% progression of the disease was observed. The mean duration of the remission was 11 months. The side-effects did practically not influence the course of the treatment.
共有79例转移性乳腺癌患者接受了长春新碱、阿霉素和环磷酰胺(VDC)联合治疗。59%的患者出现缓解,23%的患者病情未改变,18%的患者病情出现进展。缓解的平均持续时间为11个月。副作用实际上并未影响治疗过程。